Search

everythinglearnresearchcommunity

for

Search:↓

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

PRP may help treat hair loss, but results vary.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Injectable platelet-rich fibrin is a safe and effective treatment for hair loss.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Certain proteins are essential for the growth of root hairs in barley.

Jamogenin and other molecules may help treat hair loss by inhibiting 5-alpha reductase.

Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Activated platelet-rich plasma is a safe and effective treatment for hair loss.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.